Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
In a world first, researchers are harnessing data science to describe and predict when resistance to antibiotics will emerge during treatment for a bacterial infection.
Despite the thalidomide experience, research into the effects of medication during pregnancy is inadequate, including in cases where pregnant women need to continue their medication.
This week, Monash University's “What Happens Next?” podcast investigates how making reproductive healthcare inaccessible hurts us all.
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
Monash University is No.1 in the world for pharmacy and pharmacology, but what does that mean, and how are the university rankings calculated?
The new Neuromedicines Discovery Centre (NDC) aims to develop psychiatric drugs and approaches to psychedelic-assisted psychotherapies for common mental illnesses.
Researchers are exploring the medical frontier of psychedelics, and their use in facilitating psychotherapy for common mental illnesses.
Could psychedelic drugs provide the next big breakthrough in psychiatry? This episode of the ‘What Happens Next?’ podcast considers the regulatory, cultural and scientific aspects of psychedelic treatment for mental illness – and how innovation in this area could improve the lives of millions of people.
Jomo Kigotho knows from personal experience the devastating impacts of malaria. Now, the young scientist is part of a team that’s found a new weapon in the war against the disease-causing parasite.
A research project aims to boost pharmacists’ roles in neighbourhood mental health.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Researchers are delving into a protein with the potential to stop habitual drinking.
Two Monash students – and also firm friends – are on a mission to boost the uptake of the influenza vaccine.
A young pharmacist with a keen sense of legacy is working at the forefront of medicine management.
Doctors rely on independent guidelines when prescribing medication – and Mary Hemming AO is a key figure behind these.
Traces of drugs are increasingly being detected in waterways, and Dr Erinn Richmond is studying the potential harm posed to ecological environments and whether microplastics aid the transportation of drugs into the diets of aquatic creatures.
Our experts provide tips and information for those who want to better understand and embrace the idea of planetary health.
How has COVID-19 accelerated technological change, innovation and advancement in digital healthcare?
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
A team of researchers is examining how nature's "superfood" is digested, with potentially life-saving results.
Dummy text
